Patents by Inventor Matthew L. Albert

Matthew L. Albert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7989203
    Abstract: This invention relates to methods and compositions useful for delivering antigens to dendritic cells which are then useful for inducing antigen-specific cytotoxic T lymphocytes and T helper cells. This invention also provides assays for evaluating the activity of cytotoxic T lymphocytes. According to the invention, antigens are targeted to dendritic cells by apoptotic cells which may also be modified to express non-native antigens for presentation to the dendritic cells. The dendritic cells which are primed by the apoptotic cells are capable of processing and presenting the processed antigen and inducing cytotoxic T lymphocyte activity or may also be used in vaccine therapies.
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: August 2, 2011
    Assignee: The Rockefeller University
    Inventors: Matthew L. Albert, Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert Darnell
  • Patent number: 7129037
    Abstract: This invention relates to methods and compositions useful for delivering antigens to dendritic cells which are then useful for inducing antigen-specific cytotoxic T lymphocytes and T helper cells. This invention also provides assays for evaluating the activity of cytotoxic T lymphocytes. According to the invention, antigens are targeted to dendritic cells by apoptotic cells which may also be modified to express non-native antigens for presentation to the dendritic cells. The dendritic cells which are primed by the apoptotic cells are capable of processing and presenting the processed antigen and inducing cytotoxic T lymphocyte activity or may also be used in vaccine therapies.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: October 31, 2006
    Assignee: The Rockefeller University
    Inventors: Matthew L. Albert, Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert Darnell
  • Patent number: 6750029
    Abstract: Recognition of the role of a cellular immune response to immune-privileged antigens in the etiology of paraneoplastic syndromes and tumor immunity has provided diagnostic and therapeutic methods for the detection of paraneoplastic antigen-specific cells, enhancing tumor immunity by increasing the population of cytotoxic T lymphocytes (CTLs), and suppressing cellular immunity to treat the paraneoplastic syndrome. Methods for the detection of memory and cytotoxic T lymphocytes are provided which utilize immune-privileged antigens or their peptides. Enhanced CTL production is provided by stimulating antigen presenting cells in vitro with immune-privileged antigen, with and without further exposure to T lymphocytes, prior to reintroduction of either the antigen-presenting cells and/or the T lymphocytes into the patient.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: June 15, 2004
    Assignee: The Rockefeller University
    Inventors: Robert B. Darnell, Matthew L. Albert, Nina Bhardwai
  • Patent number: 6602709
    Abstract: This invention relates to methods and compositions useful for delivering antigens to dendritic cells which are then useful for inducing antigen-specific cytotoxic T lymphocytes and T helper cells. This invention also provides assays for evaluating the activity of cytotoxic T lymphocytes. According to the invention, antigens are targeted to dendritic cells by apoptotic cells which may also be modified to express non-native antigens for presentation to the dendritic cells. The dendritic cells which are primed by the apoptotic cells are capable of processing and presenting the processed antigen and inducing cytotoxic T lymphocyte activity or may also be used in vaccine therapies.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: August 5, 2003
    Assignee: The Rockefeller University
    Inventors: Matthew L. Albert, Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert Darnell
  • Publication number: 20020146396
    Abstract: This invention relates to methods and compositions useful for delivering antigens to dendritic cells which are then useful for inducing antigen-specific cytotoxic T lymphocytes and T helper cells. This invention also provides assays for evaluating the activity of cytotoxic T lymphocytes. According to the invention, antigens are targeted to dendritic cells by apoptotic cells which may also be modified to express non-native antigens for presentation to the dendritic cells. The dendritic cells which are primed by the apoptotic cells are capable,of processing and presenting the processed antigen and inducing cytotoxic T lymphocyte activity or may also be used in vaccine therapies.
    Type: Application
    Filed: December 11, 2001
    Publication date: October 10, 2002
    Inventors: Matthew L. Albert, Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba
  • Publication number: 20020004041
    Abstract: Methods are provided for preventing a cellular immune response to a pre-selected antigen by ex vivo or in vivo methods whereby dendritic cell maturation is permitted to occur in the absence of effective CD4+ T cell help. Under these conditions, elimination of cytotoxic T cells is achieved. The methods may be used for the prophylaxis of an undesired immune response to an autoimmune disease antigen, a transplant antigen, or reducing an exaggerated immune response to a antigen.
    Type: Application
    Filed: March 12, 2001
    Publication date: January 10, 2002
    Inventors: Matthew L. Albert, Mithila Jegathesan, Robert B. Darnell